ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:695. doi:10.1016/j.athoracsur.2007.06.100
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yeong Phang Lim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, L.
Right arrow Articles by Chua, Y. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, L.
Right arrow Articles by Chua, Y. L.
Related Collections
Right arrow Congenital - acyanotic


Correspondence

The Experience of Occluding Secundum Atrial Septal Defect

Liang Tao, MDa, Xiang Jun Zeng, MDa, Xiao Jing Ma, MDa, Yan Hong Luo, MDa, Yeong Phang Lim, FRCSb, Yeow Leng Chua, FRCSb

a Cardiac Surgical Department and Echocardiography Department, Wuhan Asia Heart Hospital, JingHan Ave, #753, Wuhan 430022, China
b Department of Cardiothoracic Surgery, National Heart Centre, Singapore

(Email: zengxiangjun@sohu.com; xiangjunzeng@163.com; yeongphanglim@yahoo.com).

The first 20% of the full text of this article appears below.

To the Editor:

We write in reply to the comments raised by Dixit and colleagues [1]. All the patients who underwent this procedure were ruled out from having transcutaneous device closure by our cardiology colleagues. The reasons for not considering these patients for transcutaneous closure were (1) size of defect exceeding 25 mm, (2) presence of a deficient rim (especially a deficient aortic rim), and (3) complicated or fenestrated atrial septal defect (ASD). One of the key advantages of this method is the ability to implant large devices for large ASDs regardless of femoral vessel size.

As these patients were not candidates for transcutaneous closure, the second point raised by Dixit and colleagues [1] is not valid.

We believe that the advantages of this approach are:

1 The ability to implant large devices; the largest device we . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
X. Wei, W. Yi, X. Xu, J. Zhang, J. Li, S. Yu, and D. Yi
Transthoracic occlusion for secundum atrial septal defects unsuitable for transcatheter occlusion approach
J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 113 - 119.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.